Validation of a rapid biomarker assay for lung cancer using the IntelliPlex panel

Validation of a rapid biomarker assay for lung cancer using the IntelliPlex panel

Abstract A large proportion of non-small-cell lung cancer (NSCLC) patients harbor clinically actionable genomic alterations, detected in general by broad Next-Generation Sequencing (NGS) panels, since it is the gold standard test and strongly recommended by different societies. However, high failure...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandra Satie Koide, Breno Jeha Araújo, Juliana Doblas Massaro, Renata de Godoy e Silva, Rodrigo Dienstmann, Fernanda Christtanini Koyama Ribeiro
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-10585-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items